SCHEMBL23515435

SCHEMBL23515435

CC(NC(=O)Oc1ccccc1)OC(=O)CCC(NC(=O)Oc1ccccc1)C(=O)OC(C)NC(O)Oc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 2/20 0.38
GAA P10253 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 2/20 0.38
SIRT1 Q96EB6 3/20 0.36
SIRT2 Q8IXJ6 3/20 0.36
FAAH O00519 1/20 0.36
SLC1A3 P43003 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
TSHR P16473 1/20 0.33
PSMB5 P28074 1/20 0.33
MTNR1A P48039 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23130350 0.92 NPC1 (0.37) NPC1RAB9AALDH1A1MEN1GAA
SCHEMBL21891749 0.91 CYP1A2 (0.43) NPC1RAB9AALDH1A1MEN1GAA
SCHEMBL21891888 0.82 CYP1A2 (0.41) NPC1RAB9AALDH1A1MEN1GAA
SCHEMBL21891959 0.77 POLB (0.44) GAAKMT2ACYP1A2SIRT1CYP3A4
SCHEMBL21891885 0.76 SIRT1 (0.52) NPC1RAB9ASIRT1SIRT2
SCHEMBL21891766 0.76 CYP1A2 (0.47) NPC1RAB9AALDH1A1MEN1GAA
SCHEMBL21891833 0.75 SIRT1 (0.56) SIRT1SIRT2
SCHEMBL21891752 0.75 MEN1 (0.39) NPC1RAB9AALDH1A1MEN1GAA
SCHEMBL23129807 0.73 L3MBTL1 (0.57) ALDH1A1MEN1GAAKMT2ACYP1A2
SCHEMBL21891791 0.73 L3MBTL1 (0.57) ALDH1A1MEN1GAAKMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352319-B2 Method for producing carbamate and method for producing isocyanate ASAHI KASEI KABUSHIKI KAISHA (JP) 2022-06-07 US disclosed
US-20210179548-A1 METHOD FOR PRODUCING CARBAMATE AND METHOD FOR PRODUCING ISOCYANATE ASAHI KASEI KABUSHIKI KAISHA (JP) 2021-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352319-B2 Method for producing carbamate and method for producing isocyanate CPS1, CA7, CA4 NPC1 2143/4885RAB9A 3532/4885ALDH1A1 781/4885
US-20210179548-A1 METHOD FOR PRODUCING CARBAMATE AND METHOD FOR PRODUCING ISOCYANATE CPS1, CA7, CA4 NPC1 2143/4885RAB9A 3532/4885ALDH1A1 781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.